World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
35974
World Ranking
14415
National Ranking
7292

Daniel C. Chung publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel C. Chung sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 346 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Daniel C. Chung D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel C. Chung sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of American Physical Society (APS) Citation For broad contributions to the interface of high energy theory and cosmology

Overview

Daniel C. Chung is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine with a primary focus on oncology and related subfields. Their body of work spans various topics including colorectal cancer screening, cancer genomics and diagnostics, and genetic factors in colorectal cancer.

The scientist's recent papers demonstrate engagement with both clinical and genetic research aspects. Notable publications include:

  • A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening, 2024, New England Journal of Medicine
  • Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility, 2022, Nature Genetics
  • NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021, 2021, PubMed
  • Computer-Aided Detection Improves Adenomas per Colonoscopy for Screening and Surveillance Colonoscopy: A Randomized Trial, 2022, Gastroenterology
  • Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis, 2021, Genome Medicine

Frequent collaborators include:

  • Hamed Khalili, with 13 joint works
  • Bryson W. Katona, with 12 joint works
  • Kyle Staller, with 11 joint works
  • Ramnik J. Xavier, with 10 joint works
  • Jessica McGoldrick, with 10 joint works

The venues where Daniel C. Chung most frequently publishes reflect a focus on gastrointestinal and oncological research. These include:

  • Gastroenterology (14 publications)
  • Gastrointestinal Endoscopy (5 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)
  • Cancer Prevention Research (3 publications)
  • The Laryngoscope (3 publications)

Their work spans several specialized fields within medicine:

  • Oncology (36 publications)
  • Surgery (34 publications)
  • Pulmonary and Respiratory Medicine (19 publications)
  • Pathology and Forensic Medicine (16 publications)
  • Cancer Research (13 publications)

Key research topics covered extensively include:

  • Colorectal Cancer Screening and Detection (34 publications)
  • Cancer Genomics and Diagnostics (26 publications)
  • Genetic factors in colorectal cancer (24 publications)
  • Pancreatic and Hepatic Oncology Research (24 publications)
  • Gastric Cancer Management and Outcomes (18 publications)
  • Microscopic Colitis (10 publications)
  • Radiomics and Machine Learning in Medical Imaging (8 publications)

Daniel C. Chung was recognized as a Fellow of the American Physical Society (APS) in 2016 for contributions at the interface of high energy theory and cosmology, reflecting interdisciplinary engagement beyond medicine.

Best Publications

  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Christopher G Willett;Yves Boucher;Emmanuelle di Tomaso;Dan G Duda

  • Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

    Aleksandar D. Kostic;Aleksandar D. Kostic;Eunyoung Chun;Lauren Robertson;Jonathan N. Glickman

  • Gastroenteropancreatic neuroendocrine tumours.

    Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen

  • Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

    Stephen Russell;Jean Bennett;Jennifer A. Wellman;Daniel C. Chung

  • Celecoxib for the Prevention of Sporadic Colorectal Adenomas

    Monica M. Bertagnolli;Craig J. Eagle;Ann G. Zauber;Mark Redston

  • The Chromosomal Instability Pathway in Colon Cancer

    Maria S. Pino;Daniel C. Chung

  • Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

    Albert M. Maguire;Albert M. Maguire;Katherine A. High;Katherine A. High;Alberto Auricchio;J. Fraser Wright;J. Fraser Wright

  • Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

    Terrie E Taylor;Wenjiang J Fu;Wenjiang J Fu;Richard A Carr;Richard O Whitten

  • Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands

    Choh Hao Li;David Chung

  • Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

    Rebecca C. Fitzgerald;Richard H Hardwick;David George Huntsman;Fátima Carneiro

  • Regulation of Vascular Endothelial Growth Factor by the Wnt and K-ras Pathways in Colonic Neoplasia

    Xiaobo Zhang;John P. Gaspard;Daniel C. Chung

  • Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

    Christopher G. Willett;Dan G. Duda;Emmanuelle di Tomaso;Yves Boucher

  • An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia

    Yair Benita;Hirotoshi Kikuchi;Andrew D. M. Smith;Michael Q. Zhang

  • The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

    Daniel C. Chung

  • Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells

    Yusuke Mizukami;Won-Seok Jo;Eva-Maria Duerr;Manish Gala

  • Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

    Jean Bennett;Jean Bennett;Jennifer Wellman;Kathleen A Marshall;Sarah McCague

  • Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer

    Pardeep Kaurah;Andrée MacMillan;Niki Boyd;Janine Senz

  • AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

    Jean Bennett;Jean Bennett;Manzar Ashtari;Jennifer Wellman;Kathleen A. Marshall

  • Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients

    Christopher G. Willett;Yves Boucher;Dan G. Duda;Emmanuelle Di Tomaso

  • The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.

    Daniel C Chung;Anil K Rustgi

Frequent Co-Authors

Jean Bennett
Jean Bennett University of Pennsylvania
Albert M. Maguire
Albert M. Maguire University of Pennsylvania
Gregory Y. Lauwers
Gregory Y. Lauwers Harvard University
Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Choh Hao Li
Choh Hao Li University of California, San Francisco
Sapna Syngal
Sapna Syngal Harvard Medical School
Ramnik J. Xavier
Ramnik J. Xavier Broad Institute
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Christopher G. Willett
Christopher G. Willett Duke University
Andrew T. Chan
Andrew T. Chan Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always begin with medical school, and there are many alternative and accessible online pathways to enter the healthcare field. For those already holding a registered nurse license, the most affordable accredited online rn to bsn programs offer a flexible and cost-effective way to advance professional qualifications while balancing work and life commitments.

If you’re changing careers or seeking a fast entry into advanced nursing, consider direct entry msn programs for non nurses online. These accelerated programs allow individuals with a non-nursing background to earn a Master’s in Nursing, opening doors to higher-level nursing roles.

Admission requirements vary, and finding direct entry nursing programs can help candidates identify schools with more accessible entry points, making the transition into nursing less complex.

For those interested in healthcare administration or supporting roles, accredited medical billing and coding online schools with financial aid make these career pathways both affordable and in demand, providing vital skills for today’s healthcare system.

Best Scientists Citing Daniel C. Chung

Trending Scientists

Recently Published Articles